185 related articles for article (PubMed ID: 24369060)
21. siRNA delivery using nanocarriers - an efficient tool for gene silencing.
Khurana B; Goyal AK; Budhiraja A; Arora D; Vyas SP
Curr Gene Ther; 2010 Apr; 10(2):139-55. PubMed ID: 20353386
[TBL] [Abstract][Full Text] [Related]
22. Recent progress in development of siRNA delivery vehicles for cancer therapy.
Kim HJ; Kim A; Miyata K; Kataoka K
Adv Drug Deliv Rev; 2016 Sep; 104():61-77. PubMed ID: 27352638
[TBL] [Abstract][Full Text] [Related]
23. Strategies for in vivo delivery of siRNAs: recent progress.
Higuchi Y; Kawakami S; Hashida M
BioDrugs; 2010 Jun; 24(3):195-205. PubMed ID: 20462284
[TBL] [Abstract][Full Text] [Related]
24. Comparative analysis of polymers for short interfering RNA delivery in vascular smooth muscle cells.
Bools LM; Fisher RK; Grandas OH; Kirkpatrick SS; Arnold JD; Goldman MH; Freeman MB; Mountain DJ
J Surg Res; 2015 Nov; 199(1):266-73. PubMed ID: 26272685
[TBL] [Abstract][Full Text] [Related]
25. Chitosan Nanoparticles for SiRNA Delivery In Vitro.
Ragelle H; Vanvarenberg K; Vandermeulen G; Préat V
Methods Mol Biol; 2016; 1364():143-50. PubMed ID: 26472448
[TBL] [Abstract][Full Text] [Related]
26. Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy.
Ku SH; Kim K; Choi K; Kim SH; Kwon IC
Adv Healthc Mater; 2014 Aug; 3(8):1182-93. PubMed ID: 24577795
[TBL] [Abstract][Full Text] [Related]
27. In vivo endothelial siRNA delivery using polymeric nanoparticles with low molecular weight.
Dahlman JE; Barnes C; Khan O; Thiriot A; Jhunjunwala S; Shaw TE; Xing Y; Sager HB; Sahay G; Speciner L; Bader A; Bogorad RL; Yin H; Racie T; Dong Y; Jiang S; Seedorf D; Dave A; Sandu KS; Webber MJ; Novobrantseva T; Ruda VM; Lytton-Jean AKR; Levins CG; Kalish B; Mudge DK; Perez M; Abezgauz L; Dutta P; Smith L; Charisse K; Kieran MW; Fitzgerald K; Nahrendorf M; Danino D; Tuder RM; von Andrian UH; Akinc A; Schroeder A; Panigrahy D; Kotelianski V; Langer R; Anderson DG
Nat Nanotechnol; 2014 Aug; 9(8):648-655. PubMed ID: 24813696
[TBL] [Abstract][Full Text] [Related]
28. Progress in siRNA delivery using multifunctional nanoparticles.
Gao W; Xiao Z; Radovic-Moreno A; Shi J; Langer R; Farokhzad OC
Methods Mol Biol; 2010; 629():53-67. PubMed ID: 20387142
[TBL] [Abstract][Full Text] [Related]
29. Polymers for siRNA delivery: inspired by viruses to be targeted, dynamic, and precise.
Wagner E
Acc Chem Res; 2012 Jul; 45(7):1005-13. PubMed ID: 22191535
[TBL] [Abstract][Full Text] [Related]
30. Polyethylenimines for siRNA and miRNA delivery in vivo.
Höbel S; Aigner A
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):484-501. PubMed ID: 23720168
[TBL] [Abstract][Full Text] [Related]
31. Polyethylenimine as a promising vector for targeted siRNA delivery.
Nimesh S
Curr Clin Pharmacol; 2012 May; 7(2):121-30. PubMed ID: 22432843
[TBL] [Abstract][Full Text] [Related]
32. Cationic lipids and polymers mediated vectors for delivery of siRNA.
Zhang S; Zhao B; Jiang H; Wang B; Ma B
J Control Release; 2007 Oct; 123(1):1-10. PubMed ID: 17716771
[TBL] [Abstract][Full Text] [Related]
33. [Types of non-viral delivery systems of small interfering RNA].
Glebova KV; Marakhonov AV; Baranova AV; Skoblov MIu
Mol Biol (Mosk); 2012; 46(3):387-401. PubMed ID: 22888629
[TBL] [Abstract][Full Text] [Related]
34. Journey of siRNA: Clinical Developments and Targeted Delivery.
Nikam RR; Gore KR
Nucleic Acid Ther; 2018 Aug; 28(4):209-224. PubMed ID: 29584585
[TBL] [Abstract][Full Text] [Related]
35. Nonviral pulmonary delivery of siRNA.
Merkel OM; Kissel T
Acc Chem Res; 2012 Jul; 45(7):961-70. PubMed ID: 21905687
[TBL] [Abstract][Full Text] [Related]
36. Bioengineered nanoparticles for siRNA delivery.
Kozielski KL; Tzeng SY; Green JJ
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2013; 5(5):449-68. PubMed ID: 23821336
[TBL] [Abstract][Full Text] [Related]
37. A biodegradable amphiphilic and cationic triblock copolymer for the delivery of siRNA targeting the acid ceramidase gene for cancer therapy.
Mao CQ; Du JZ; Sun TM; Yao YD; Zhang PZ; Song EW; Wang J
Biomaterials; 2011 Apr; 32(11):3124-33. PubMed ID: 21277018
[TBL] [Abstract][Full Text] [Related]
38. Structural modification of siRNA for efficient gene silencing.
Lee SJ; Son S; Yhee JY; Choi K; Kwon IC; Kim SH; Kim K
Biotechnol Adv; 2013; 31(5):491-503. PubMed ID: 22985697
[TBL] [Abstract][Full Text] [Related]
39. Targeted gene silencing by small interfering RNA-based knock-down technology.
Zhang J; Hua ZC
Curr Pharm Biotechnol; 2004 Feb; 5(1):1-7. PubMed ID: 14965205
[TBL] [Abstract][Full Text] [Related]
40. Stimuli-responsive hybrid nanocarriers developed by controllable integration of hyperbranched PEI with mesoporous silica nanoparticles for sustained intracellular siRNA delivery.
Prabhakar N; Zhang J; Desai D; Casals E; Gulin-Sarfraz T; Näreoja T; Westermarck J; Rosenholm JM
Int J Nanomedicine; 2016; 11():6591-6608. PubMed ID: 27994460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
